Cardiovascular diseases are one of the leading causes of death worldwide. It has been analyzed that sedentary lifestyle, changing dietary habits and surge in associated risk factors are likely to increase the number of patients with cardiovascular diseases. To treat the diseases, key players are investing in to develop new drugs with better efficacy and less side effects. Due to this, the global market for cardiovascular drugs are highly active and estimated to display sustained growth in the coming years, finds a new study added to the broad database of Market Research Hub (MRH). The research study is titled as “Cardiovascular Drugs: Global Markets to 2022”, which presents a complete perspective on global cardiovascular drugs market’s evolution throughout the forecast period of 2017-2022 in terms of revenue (in US$ Bn).
Click here for Free Sample Report@ https://www.marketresearchhub.com/enquiry.php?type=S&repid=1657225
In the initial section, the research offers a brief overview of the cardiovascular drugs covering market definition, epidemiology of cardiovascular diseases and blockbuster drugs utilized for the treatment. In addition, a look at the regulatory environment, which has been a driving force in drug development is also mentioned in the study. It has been investigated that increase in the prevalence of heart diseases together with rising geriatric population and lifestyle-related diseases have created wider demand for effective cardiovascular drugs. According to the key findings, the global cardiovascular drugs market should reach $149.4 billion by 2022 from $141.1 billion in 2017 at a compound annual growth rate (CAGR) of 1.2%, from 2017 to 2022.
As the report proceeds, analysis of the key drivers, restraints, opportunities, and threats have been offered lucidly for the perusal of readers. Also, information on competitor initiatives and data with regard to demand for specialty chemicals used to develop new products and for new applications are also outlined. Some of the prime market drivers include:
- Prevalence of Comorbidities Such as Diabetes and Obesity
- Emergence of Effective Therapies for Hypertension and Hyperlipidemia
- Government Regulations Improving Prescription Drug Assistance for the Elderly
It has been also stated in the study that emergence of combination therapy acts as a major opportunity to the cardiovascular drugs market. This research report states that to understand the complete pipeline drug development, an overall overview of each product in therapeutic development for all indication are discussed. The report offers comprehensive information about the products along with a complete overview of the all individual pipeline program in all indications. The pipeline analysis section offers the current scenario of cardiovascular investments for research and development, novel drug development/approval, and promising pipeline molecules/drugs in development.
A detailed market segmentation is also included in the study for a clear understanding. It has been analyzed on the basis of disease areas, drug class and region. Regionally, the research highlights North America, Europe, Asia-Pacific, MEA and South America.
Furthermore, the research study throws light on the competitive landscape of the cardiovascular drugs market across the globe. In addition, the company profiles, product catalog, financial overview, and recent developments of the key players have been mentioned in the research report. Company profiles of the major players in the market, include Gilead Sciences Inc. Daiichi Sankyo Company Ltd., Johnson & Johnson, Novartis AG, AstraZeneca PLC, United Therapeutics Corp., and Pfizer Inc.
Enquire about this Report@ https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1657225
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like pharmaceutical industry reports and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
Contact Us
90 State Street,
Albany, NY 12207,
United States
Toll Free: 800-998-4852 (US-Canada)
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/
Read Industry News at - https://www.industrynewsanalysis.com/